Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis

References

• KearneyPMWheltonMReynoldsKMuntnerPWheltonPKHeJGlobal burden of hypertension: analysis of worldwide dataLancet2005365945521722315652604
   PubMed Web of Science ®Google Scholar
• WhitingDRGuariguataLWeilCShawJIDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Res Clin Pract201194331132122079683
   PubMed Web of Science ®Google Scholar
• KannelWBBlood pressure as a cardiovascular risk factor: prevention and treatmentJAMA199627520157115768622248
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNPetoRCollinsRProspective Studies CollaborationAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet200236093491903191312493255
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionAge-Adjusted Percentage of Adults Aged 18 Years or Older with Diagnosed Diabetes Who have Hypertension, United States, 1995–2009 Available from: http://www.cdc.gov/diabetes/statistics/comp/fig8.htmAccessed June 30, 2014
   Google Scholar
• ChokshiNPGrossmanEMesserliFHBlood pressure and diabetes: vicious twinsHeart201399857758523434624
   PubMed Web of Science ®Google Scholar
• [No authors listed]Hypertension in Diabetes Study (HDS). II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patientsJ Hypertens19931133193258387090
   PubMed Web of Science ®Google Scholar
• TurnerRCMillnsHNeilHARisk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)BMJ199831671348238289549452
   PubMed Web of Science ®Google Scholar
• ChenGMcAlisterFAWalkerRLHemmelgarnBRCampbellNRCardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressureHypertension201157589189721403089
   PubMed Web of Science ®Google Scholar
• JamesPAOparilSCarterBLEvidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2013Diabetes Care201336Suppl 1S11S6623264422
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• BrownMJCastaigneAde LeeuwPWInfluence of diabetes and type of hypertension on response to antihypertensive treatmentHypertension20003551038104210818061
   PubMed Web of Science ®Google Scholar
• AmarJChamontinBGenesNCantetCSalvadorMCambouJPWhy is hypertension so frequently uncontrolled in secondary prevention?J Hypertens20032161199120512777958
   PubMed Web of Science ®Google Scholar
• ManciaGAmbrosioniERoseiEABlood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife studyJ Hypertens20052381575158116003185
   PubMed Web of Science ®Google Scholar
• WeberMABakrisGLJamersonKCardiovascular events during differing hypertension therapies in patients with diabetesJ Am Coll Cardiol2010561778520620720
   PubMed Web of Science ®Google Scholar
• KuznikAMardekianJTrends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the US diabetic population, 1999–2008Cardiovasc Diabetol2011103121496321
   PubMed Web of Science ®Google Scholar
• Stark CasagrandeSFradkinJESaydahSHRustKFCowieCCThe prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010Diabetes Care20133682271227923418368
   PubMed Web of Science ®Google Scholar
• TurnbullFNealBAlgertCEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med2005165121410141915983291
   PubMedGoogle Scholar
• Norvasc^® (amlodipine besylate) tablets [prescribing information]United StatesPfizer Inc., New York, NY, USA2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019787s053lbl.pdfAccessed May 8, 2014
   Google Scholar
• TattiPPahorMByingtonRPOutcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDMDiabetes Care19982145976039571349
   PubMed Web of Science ®Google Scholar
• SharmaAMBakrisGNeutelJMSingle-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trialClin Ther201234353755122386829
   PubMed Web of Science ®Google Scholar
• VarroneJInvestigators of Study AML-NY-86-002The efficacy and safety of amlodipine in the treatment of mild and moderate essential hypertension in general practiceJ Cardiovasc Pharmacol199117Suppl 1S30S3316296705
   PubMedGoogle Scholar
• FujiwaraTIiYHatsuzawaJThe Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once dailyJ Hum Hypertens200923852152919148107
   PubMed Web of Science ®Google Scholar
• FukutomiMHoshideSEguchiKWatanabeTShimadaKKarioKDifferential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET studyJ Am Soc Hypertens201261738222054782
   PubMed Web of Science ®Google Scholar
• KarioKRobbinsJJeffersBWTitration of amlodipine to higher doses: a comparison of Asian and Western experienceVasc Health Risk Manag2013969570124235839
   PubMedGoogle Scholar
• HongSJAhnTHBaekSHComparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trialClin Ther200628453755116750465
   PubMed Web of Science ®Google Scholar
• ChanISZhangZTest-based exact confidence intervals for the difference of two binomial proportionsBiometrics19995541202120911315068
   PubMed Web of Science ®Google Scholar
• BobrieGI-COMBINE Study InvestigatorsI-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation studyClin Ther20123481705171922853848
   PubMed Web of Science ®Google Scholar
• KangSMYounJCChaeSCComparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority studyClin Ther201133121953196322136978
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention National Center for Health Statistics Division of Health Interview StatisticsCrude and Age-Adjusted Percentage of Civilian, Noninstitutionalized Adults with Diagnosed Diabetes, United States, 1980–2011 Available from: http://www.cdc.gov/diabetes/statistics/prev/national/figageadult.htmAccessed June 30, 2014
   Google Scholar
• GressTWNietoFJShaharEWoffordMRBrancatiFLHypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities StudyN Engl J Med20003421390591210738048
   PubMed Web of Science ®Google Scholar
• AdlerAIStrattonIMNeilHAAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ2000321725841241910938049
   PubMed Web of Science ®Google Scholar
• [No authors listed]Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupBMJ199831771607037139732337
   PubMed Web of Science ®Google Scholar
• PatelAADVANCE Collaborative GroupMacMahonSEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet2007370959082984017765963
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983519118175517629635947
   PubMed Web of Science ®Google Scholar
• ACCORD Study GroupCushmanWCEvansGWEffects of intensive blood-pressure control in type 2 diabetes mellitusN Engl J Med2010362171575158520228401
   PubMed Web of Science ®Google Scholar
• Cooper-DeHoffRMGongYHandbergEMTight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery diseaseJAMA20103041616820606150
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA2002288232981299712479763
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436394262022203115207952
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet2005366948989590616154016
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008359232417242819052124
   PubMed Web of Science ®Google Scholar
• BakrisGLMaximizing cardiorenal benefit in the management of hypertension: achieve blood pressure goalsJ Clin Hypertens (Greenwich)19991214114711416606
   PubMedGoogle Scholar